| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_CADPS2_0017700 | Exon-Exon | chr7:122255235-122303623 | chr7:122615181-122663569 | 125 nt | 0.4480 |
| hsa_CADPS2_0017300 | Intron-Exon-Intron | chr7:122255235-122342816 | chr7:122615181-122702762 | 250 nt | 0.3560 |
| hsa_CADPS2_0017800 | Exon-Exon | chr7:122255235-122377122 | chr7:122615181-122737068 | 950 nt | 0.4158 |
| hsa_CADPS2_0017900 | Intron-Exon-Intron | chr7:122255235-122388730 | chr7:122615181-122748676 | 303 nt | 0.4323 |
| hsa_CADPS2_0018000 | Intron-Exon-Intron | chr7:122257519-122269382 | chr7:122617465-122629328 | 81 nt | 0.4938 |
| hsa_CADPS2_0018100 | Exon-Exon | chr7:122261535-122269382 | chr7:122621481-122629328 | 318 nt | 0.4025 |
| hsa_CADPS2_0018200 | Exon-Exon | chr7:122261657-122303611 | chr7:122621603-122663557 | 517 nt | 0.4159 |
| hsa_CADPS2_0018400 | Exon-Exon | chr7:122269302-122303623 | chr7:122629248-122663569 | 87 nt | 0.4713 |
| hsa_CADPS2_0018300 | Exon-Exon | chr7:122269302-122377122 | chr7:122629248-122737068 | 528 nt | 0.4318 |
| hsa_chr7_0100100 | Intergenic-Intergenic | chr7:122276799-122282106 | chr7:122636745-122642052 | 250 nt | 0.3520 |
A review of studies in humans, mice, and rats indicates that the circCADPS2 demonstrates stable expression in myocardial tissue and body fluids, with specific expression patterns associated with sudden cardiac death-related diseases [Tian et al. DOI:10.3390/molecules26041155]. A study in human traumatic brain injury (TBI) patients identified the circCADPS2 as a top up-regulated circular RNA (fold change 17.62) in brain injury tissues compared to adjacent contusion tissues, with its increased expression validated by qRT-PCR [Li et al. DOI:10.3389/fneur.2022.1086553].